AI and the Pharmaceutical Industry — 2026-10-20 (Tue)
This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer
Harvested 434Accepted 3Stale 91Duplicate 67Low-quality source 19Market noise 7Market research 2Off-topic 222No investment signal 23
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
| Amount | Deal | Function | Source |
|---|---|---|---|
| $1.1B | Lilly partners with Hong Kong's Metis in $1.1B deal to bolster AI nanoparticle discovery | 🏛️ Enterprise AI Platform & Governance | Fierce Biotech |
| up to $1.1 Billion | METiS TechBio, Eli Lilly Sign AI-Driven Drug-Delivery Deal With Up to $1.1 Billion in Milestones | 🏛️ Enterprise AI Platform & Governance | marketscreener.com |
🧬 Drug Discovery0
No items today · See past 90 days →
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance3
- S4 Amount disclosedLilly partners with Hong Kong's Metis in $1.1B deal to bolster AI nanoparticle discovery$1.1B — Fierce Biotech10/19 23:45 JST
- S4 Amount disclosedMETiS TechBio, Eli Lilly Sign AI-Driven Drug-Delivery Deal With Up to $1.1 Billion in Milestonesup to $1.1 Billion — marketscreener.com10/19 20:19 JSTEli Lilly
- S1 DeploymentAI Tracking in Biopharma: Accelerated Large-Scale Deployment by Major Pharma Companies; Valuation Re-rating Hinges on R&D Productivity Gains — 富途牛牛10/19 15:02 JST